Study of Plozasiran in Adults With Severe Hypertriglyceridemia
Clinical trial NCT06347016 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06347016
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-23
- Primary completion
- 2026-06-17
- Enrollment
- 311
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.